ZAM
GSK icon

Zevin Asset Management’s GSK GSK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-53,806
Closed -$1.58M 78
2022
Q3
$1.58M Sell
53,806
-16,144
-23% -$475K 0.37% 44
2022
Q2
$3.05M Buy
69,950
+15,636
+29% +$681K 0.69% 37
2022
Q1
$2.37M Buy
54,314
+15,877
+41% +$692K 0.45% 42
2021
Q4
$1.7M Buy
38,437
+4,177
+12% +$184K 0.31% 45
2021
Q3
$1.31M Buy
34,260
+5,669
+20% +$217K 0.25% 46
2021
Q2
$1.14M Buy
28,591
+108
+0.4% +$4.3K 0.23% 47
2021
Q1
$1.02M Buy
28,483
+3,833
+16% +$137K 0.22% 48
2020
Q4
$907K Buy
24,650
+2,375
+11% +$87.4K 0.21% 47
2020
Q3
$838K Hold
22,275
0.23% 46
2020
Q2
$909K Buy
22,275
+770
+4% +$31.4K 0.28% 45
2020
Q1
$815K Buy
21,505
+709
+3% +$26.9K 0.3% 45
2019
Q4
$977K Sell
20,796
-1,905
-8% -$89.5K 0.3% 48
2019
Q3
$969K Sell
22,701
-4,340
-16% -$185K 0.31% 50
2019
Q2
$1.08M Sell
27,041
-5,400
-17% -$216K 0.35% 47
2019
Q1
$1.36M Sell
32,441
-510
-2% -$21.3K 0.44% 46
2018
Q4
$1.26M Sell
32,951
-3,030
-8% -$116K 0.46% 46
2018
Q3
$1.45M Sell
35,981
-200
-0.6% -$8.03K 0.42% 50
2018
Q2
$1.46M Sell
36,181
-6,950
-16% -$280K 0.44% 51
2018
Q1
$1.69M Sell
43,131
-25,375
-37% -$991K 0.44% 50
2017
Q4
$2.43M Buy
68,506
+13,250
+24% +$470K 0.55% 48
2017
Q3
$2.24M Buy
55,256
+775
+1% +$31.5K 0.53% 49
2017
Q2
$2.35M Sell
54,481
-2,802
-5% -$121K 0.59% 44
2017
Q1
$2.42M Sell
57,283
-17,037
-23% -$718K 0.61% 41
2016
Q4
$2.86M Buy
74,320
+1,360
+2% +$52.4K 0.75% 37
2016
Q3
$3.15M Sell
72,960
-5,000
-6% -$216K 1.02% 30
2016
Q2
$3.38M Buy
77,960
+16,680
+27% +$723K 0.94% 29
2016
Q1
$2.49M Sell
61,280
-7,350
-11% -$298K 0.7% 40
2015
Q4
$2.77M Buy
68,630
+2,480
+4% +$100K 0.73% 39
2015
Q3
$2.54M Buy
66,150
+1,750
+3% +$67.3K 0.74% 42
2015
Q2
$2.68M Buy
64,400
+455
+0.7% +$18.9K 0.72% 44
2015
Q1
$2.95M Sell
63,945
-355
-0.6% -$16.4K 0.81% 42
2014
Q4
$2.75M Buy
+64,300
New +$2.75M 0.77% 47